Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 22, Number 1—January 2016


Schistosomiasis Screening of Travelers to Corsica, France

On This Page

Article Metrics

citations of this article
EID Journal Metrics on Scopus

Cite This Article


Highlight and copy the desired format.

EID Berry A, Paris L, Boissier J, Caumes E. Schistosomiasis Screening of Travelers to Corsica, France. Emerg Infect Dis. 2016;22(1):159.
AMA Berry A, Paris L, Boissier J, et al. Schistosomiasis Screening of Travelers to Corsica, France. Emerging Infectious Diseases. 2016;22(1):159. doi:10.3201/eid2201.151290.
APA Berry, A., Paris, L., Boissier, J., & Caumes, E. (2016). Schistosomiasis Screening of Travelers to Corsica, France. Emerging Infectious Diseases, 22(1), 159.

To the editor: As members of the French Ministry of Health Working Group on autochthonous urinary schistosomiasis, we read with interest the 2 recently published articles regarding schistosomiasis screening of travelers to Corsica, France (1,2). Surprisingly, the authors of both articles lacked evidence to support the diagnosis of schistosomiasis in most of what they referred to as confirmed cases. The diagnostic standard for confirmation of urinary schistosomiasis is identification of eggs by microscopic examination of urine samples (35). If this criterion were applied in both reports, only 1 patient of the 7 allegedly confirmed cases would actually be confirmed.

The low sensitivity of microscopy is well known. Therefore, different serologic tests have been developed, including Western blot (WB). In the study based on travelers from Italy (1), the SCHISTO II WB IgG test (LDBIO Diagnostics, Lyon, France) was used. This test, available since 2015, is based on both Schistosoma haematobium and S. mansoni antigens and has not been evaluated by anyone other than the manufacturer. Moreover, the authors did not report any details regarding the molecular weight and number of specific bands observed on the strip.

In the study by authors from the GeoSentinel Surveillance Network (2), both cases that could have been infected after 2013, since exposure occurred only in 2014, and 4 cases which reported bathing in rivers in Corsica other than the Cavu River had just 1 weakly positive serologic screening test. Hence, irrespective of the criteria for a confirmed case of schistosomiasis described above, it appears difficult to conclude that confirmation could rely on only 1 positive serologic test, even a WB.

Altogether, these 2 studies identified only 1 patient with parasitological evidence of infection that was attributable to the already known 2013 focus in Cavu River. Therefore, these articles do not provide evidence of transmission of schistosomiasis in Corsica after 2013 or outside the Cavu River.


Antoine BerryComments to Author , Luc Paris, Jérôme Boissier, and Eric Caumes

Author affiliations: Toulouse University Hospital, Toulouse, France (A. Berry); Public Assistance Hospitals of Paris, Paris, France (L. Paris, E. Caumes); University of Perpignan Via Domitia, Perpignan, France; National Centre of Scientific Research, Perpignan (J. Boissier)



  1. Beltrame  A, Zammarchi  L, Zuglian  G, Gobbi  F, Angheben  A, Marchese  V, Schistosomiasis screening of travelers from Italy with possible exposure in Corsica, France. Emerg Infect Dis. 2015;21:18879 . DOIPubMed
  2. Gautret  P, Mockenhaupt  FP, von Sonnenburg  F, Rothe  C, Libman  M, Van De Winkel  K, Local and international implications of schistosomiasis acquired in Corsica, France. Emerg Infect Dis. 2015;21:18658. DOIPubMed
  3. Gryseels  B, Strickland  GT. Schistosomiasis. In: Magill AJ, Ryan ET, Hill DR, Solomon T, editors. Hunter’s tropical medicine and emerging infectious diseases, 9th ed. London: Elsevier Saunders; 2013. p. 868.
  4. Maguire  JH. Trematodes. Schistosomes and other flukes. In: Mandell GL, Bennett JE, Dolin JE, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 7th ed. Philadelphia: Churchill Livingstone Elsevier Philadelphia; 2010. p. 3595–3606.
  5. World Health Organization. WHO recommended surveillance standards. 2nd ed. WHO/CDS/CSR/ISR/99/2/EN. Geneva: The Organization; 2015. p 107 [cited 2015 July 22].


Cite This Article

DOI: 10.3201/eid2201.151290

Related Links


Table of Contents – Volume 22, Number 1—January 2016


Please use the form below to submit correspondence to the authors or contact them at the following address:

Antoine Berry, Service de Parasitologie-Mycologie, IFB, Hôpital Purpan, Centre Hospitalier Universitaire de Toulouse, TSA 40031–31059 Toulouse, CEDEX 9, France

character(s) remaining.

Comment submitted successfully, thank you for your feedback.